- Home
- RVPH vs JJSF Comparison
RVPH vs JJSF Comparison
Compare RVPH & JJSF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- JJSF
- Stock Information
- Founded
- RVPH 2006
- JJSF 1971
- Country
- RVPH United States
- JJSF United States
- Employees
- RVPH N/A
- JJSF N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- JJSF Specialty Foods
- Sector
- RVPH Health Care
- JJSF Consumer Staples
- Exchange
- RVPH Nasdaq
- JJSF Nasdaq
- Market Cap
- RVPH 32.8M
- JJSF N/A
- IPO Year
- RVPH N/A
- JJSF N/A
- Fundamental
- Price
- RVPH $0.40
- JJSF $116.61
- Analyst Decision
- RVPH Strong Buy
- JJSF Buy
- Analyst Count
- RVPH 5
- JJSF 2
- Target Price
- RVPH $9.00
- JJSF $142.50
- AVG Volume (30 Days)
- RVPH 3.4M
- JJSF 188.7K
- Earning Date
- RVPH 08-13-2025
- JJSF 08-04-2025
- Dividend Yield
- RVPH N/A
- JJSF 2.68%
- EPS Growth
- RVPH N/A
- JJSF N/A
- EPS
- RVPH N/A
- JJSF 3.89
- Revenue
- RVPH N/A
- JJSF $1,585,410,000.00
- Revenue This Year
- RVPH N/A
- JJSF $3.64
- Revenue Next Year
- RVPH N/A
- JJSF $3.68
- P/E Ratio
- RVPH N/A
- JJSF $29.92
- Revenue Growth
- RVPH N/A
- JJSF 0.49
- 52 Week Low
- RVPH $0.30
- JJSF $109.71
- 52 Week High
- RVPH $4.28
- JJSF $180.80
- Technical
- Relative Strength Index (RSI)
- RVPH 33.44
- JJSF 50.81
- Support Level
- RVPH $0.35
- JJSF $115.10
- Resistance Level
- RVPH $0.83
- JJSF $119.24
- Average True Range (ATR)
- RVPH 0.06
- JJSF 3.23
- MACD
- RVPH -0.01
- JJSF 0.43
- Stochastic Oscillator
- RVPH 17.36
- JJSF 58.10
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.